» Articles » PMID: 37346380

Obesity, Obesity-related Metabolic Conditions, and Risk of Thyroid Cancer in Women: Results from a Prospective Cohort Study (Sister Study)

Overview
Date 2023 Jun 22
PMID 37346380
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Thyroid cancer incidence has increased worldwide. Obesity trends may play a role, but the underlying biological pathways are not well-characterized. Therefore, we examined associations of excess adiposity and obesity-related metabolic conditions with thyroid cancer incidence.

Methods: From the Sister Study, a cohort of sisters of women with breast cancer, we included 47,739 women who were cancer-free at baseline (2003-2009). Height, weight, waist and hip circumference, and blood pressure were measured at baseline and medical history was self-reported. Cox proportional hazards regression models were adjusted for age (time scale), race/ethnicity, smoking, baseline history of benign thyroid disease, and frequency of routine healthcare visits.

Findings: During follow-up (median = 12.5; max = 15.9 years), 259 women reported incident thyroid cancer. Body mass index (BMI) (hazard ratio [HR] = 1.25, 95% CI = 1.14-1.37), waist circumference (HR = 1.11, 95% CI = 1.06-1.15), and waist-to-hip ratio (HR  = 1.49, 95% CI = 1.14-1.94) were positively associated with thyroid cancer incidence, as were metabolic syndrome (HR = 1.67, 95% CI = 1.24-2.25), dyslipidemia (HR = 1.46, 95% CI = 1.13-1.90), borderline diabetes (HR = 2.06, 95% CI = 1.15-3.69), hypertension (HR = 1.49, 95% CI = 1.12-1.96), and polycystic ovary syndrome (PCOS, HR = 2.10, 95% CI = 1.20-3.67). These associations were attenuated with additional BMI adjustment, although dyslipidemia (HR = 1.35, 95% CI = 1.04-1.75) and PCOS (HR = 1.86, 95% CI = 1.06-3.28) remained associated with thyroid cancer incidence. Hypothyroidism was not associated with thyroid cancer.

Interpretation: In this cohort of sisters of women diagnosed with breast cancer, excess adiposity and several obesity-related metabolic conditions were associated with thyroid cancer incidence. These findings provide insights into potential biological mechanisms linking obesity and thyroid cancer.

Funding: This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute and National Institute of Environmental Health Sciences (Z01-ES044005).

Citing Articles

Differences and analogies in thyroid cancer discovered incidentally or by thyroid related screening: A multicenter study.

Croce L, Ruggeri R, Virili C, Cappelli C, Teliti M, Costa P Eur Thyroid J. 2025; .

PMID: 39841635 PMC: 11825167. DOI: 10.1530/ETJ-24-0190.


Association of metabolic obesity phenotypes with risk of overall and site-specific cancers: a systematic review and meta-analysis of cohort studies.

Mahamat-Saleh Y, Aune D, Freisling H, Hardikar S, Jaafar R, Rinaldi S Br J Cancer. 2024; 131(9):1480-1495.

PMID: 39317703 PMC: 11519895. DOI: 10.1038/s41416-024-02857-7.


Translocase of Outer Mitochondrial Membrane 40, as a Promising Biomarker for the Diagnosis of Polycystic Ovary Syndrome and Pan-Cancer.

Zhang X, Zhu L, Ma C, Zhao S, Zhao C, Sun H Reprod Sci. 2024; 31(11):3569-3582.

PMID: 39060752 PMC: 11527956. DOI: 10.1007/s43032-024-01652-2.


Role of body mass index and weight change in the risk of cancer: A systematic review and meta-analysis of 66 cohort studies.

Shi X, Deng G, Wen H, Lin A, Wang H, Zhu L J Glob Health. 2024; 14:04067.

PMID: 38547495 PMC: 10978059. DOI: 10.7189/jogh.14.04067.


Organochlorine pesticides and risk of papillary thyroid cancer in U.S. military personnel: a nested case-control study.

Rusiecki J, McAdam J, Denic-Roberts H, Sjodin A, Davis M, Jones R Environ Health. 2024; 23(1):28.

PMID: 38504322 PMC: 10949709. DOI: 10.1186/s12940-024-01068-0.


References
1.
Haugen B . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?. Cancer. 2016; 123(3):372-381. DOI: 10.1002/cncr.30360. View

2.
Rinaldi S, Plummer M, Biessy C, Tsilidis K, Nautrup Ostergaard J, Overvad K . Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst. 2014; 106(6):dju097. DOI: 10.1093/jnci/dju097. View

3.
Almquist M, Johansen D, Bjorge T, Ulmer H, Lindkvist B, Stocks T . Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control. 2011; 22(5):743-51. DOI: 10.1007/s10552-011-9747-2. View

4.
Calle E, Kaaks R . Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4(8):579-91. DOI: 10.1038/nrc1408. View

5.
Clero E, Leux C, Brindel P, Truong T, Anger A, Teinturier C . Pooled analysis of two case-control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area. Thyroid. 2010; 20(11):1285-93. DOI: 10.1089/thy.2009.0456. View